Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.030 Biomarker disease BEFREE Here we show that in the chronic helminth infection onchocerciasis (river blindness), where patients have relatively little sign of dermatitis despite the presence of millions of small worms in the skin, T cells can be obtained which bear characteristics of Tr1 cells, producing no IL-2 or IL-4 but substantial amounts of IL-10, variable amounts of IL-5, and some IFN-gamma. 12443893 2002
Entrez Id: 3567
Gene Symbol: IL5
IL5
0.030 Biomarker disease BEFREE Here we show that in the chronic helminth infection onchocerciasis (river blindness), where patients have relatively little sign of dermatitis despite the presence of millions of small worms in the skin, T cells can be obtained which bear characteristics of Tr1 cells, producing no IL-2 or IL-4 but substantial amounts of IL-10, variable amounts of IL-5, and some IFN-gamma. 12443893 2002
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.030 AlteredExpression disease BEFREE Induction of IL-5 at the mRNA level and IL-5 and IL-10 at the protein level was demonstrated in patients with the generalized form of onchocerciasis and endemic normals without clinical manifestations. 9294549 1997
Entrez Id: 3567
Gene Symbol: IL5
IL5
0.030 AlteredExpression disease BEFREE Induction of IL-5 at the mRNA level and IL-5 and IL-10 at the protein level was demonstrated in patients with the generalized form of onchocerciasis and endemic normals without clinical manifestations. 9294549 1997
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.030 AlteredExpression disease BEFREE Furthermore, spontaneous production of high levels of IL-10 in onchocerciasis patients is likely to suppress Th1-type immunity, and thus may favour manifestation of chronic onchocerciasis. 8706329 1996
Entrez Id: 3567
Gene Symbol: IL5
IL5
0.030 Biomarker disease BEFREE These findings suggest that IL-2 production is required to induce IL-5 and further implicates IL-5 as a possible mediator of protection in onchocerciasis. 8099937 1993
Entrez Id: 25928
Gene Symbol: SOSTDC1
SOSTDC1
0.020 Biomarker disease BEFREE Simulium perplexum Shelley, Maia-Herzog, Luna Dias & Couch is structurally similar in the pupal stage to Simulium guianense Wise, the main vector in the onchocerciasis foci of Amazonian Brazil and Venezuela. 28359830 2017
Entrez Id: 25928
Gene Symbol: SOSTDC1
SOSTDC1
0.020 Biomarker disease BEFREE Simulium guianense Wise is a Latin American vector complex of black flies associated with transmission of the causal agent of human onchocerciasis (river blindness). 28727841 2017
Entrez Id: 84706
Gene Symbol: GPT2
GPT2
0.020 Biomarker disease BEFREE The ratios of nonsynonymous (K(a)) to synonymous (K(s)) mutation frequencies (ω) were calculated for the alt-2 genes of the lymphatic filariasis agents Brugia malayi and Wuchereria bancrofti and the agents of river blindness and African eyeworm disease Onchocerca volvulus and Loa loa. 26890364 2016
Entrez Id: 84706
Gene Symbol: GPT2
GPT2
0.020 GeneticVariation disease BEFREE By screening an L3 cDNA library with sera from uninfected longstanding residents of an area endemic for onchocerciasis, so-called "endemic normals" (EN), we have cloned and characterized one such gene termed the abundant larval transcript two (ALT-2). 15611611 2004
Entrez Id: 440163
Gene Symbol: RNASE13
RNASE13
0.020 Biomarker disease BEFREE The striking similarity of the parasite Ag and the human autoantigen has led to the hypothesis that RAL1 may induce a cross-reactive immune response to calreticulin, which in turn may be involved in the pathogenesis of onchocerciasis. 7520419 1994
Entrez Id: 440163
Gene Symbol: RNASE13
RNASE13
0.020 Biomarker disease BEFREE The encoded polypeptide also shows a 64.4% identity with RAL-1, an Ag of the river blindness pathogen Onchocerca volvulus. 1919005 1991
Entrez Id: 23263
Gene Symbol: MCF2L
MCF2L
0.010 GeneticVariation disease BEFREE Analysis revealed that serum concentrations (calculated from DBS) within the respective reference ranges were attained in only 52.9% of the 68 Nodding syndrome patients treated with valproic acid, in 21.4% of the 56 Ugandan epilepsy patients treated with carbamazepine, and in 65.7% of the 137 onchocerciasis-associated epilepsy patients from the DRC treated with phenobarbital. 31834012 2019
Entrez Id: 4036
Gene Symbol: LRP2
LRP2
0.010 GeneticVariation disease BEFREE Analysis revealed that serum concentrations (calculated from DBS) within the respective reference ranges were attained in only 52.9% of the 68 Nodding syndrome patients treated with valproic acid, in 21.4% of the 56 Ugandan epilepsy patients treated with carbamazepine, and in 65.7% of the 137 onchocerciasis-associated epilepsy patients from the DRC treated with phenobarbital. 31834012 2019
Entrez Id: 5898
Gene Symbol: RALA
RALA
0.010 Biomarker disease BEFREE Presently Ov-103 and Ov-RAL-2 are the most promising vaccine candidates against an Onchocerca volvulus infection. 31525197 2019
Entrez Id: 2288
Gene Symbol: FKBP4
FKBP4
0.010 Biomarker disease BEFREE Humans are the definitive host of Onchocerca volvulus, but the simuliid vectors feed on a range of animals and HBI is a key indicator of the potential for human onchocerciasis transmission. 27494934 2016
Entrez Id: 3172
Gene Symbol: HNF4A
HNF4A
0.010 Biomarker disease BEFREE The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer. 25143352 2014
Entrez Id: 3117
Gene Symbol: HLA-DQA1
HLA-DQA1
0.010 Biomarker disease BEFREE In both populations, there is strong evidence related to the protective role of DQA1*0401 against onchocerciasis. 22117902 2012
Entrez Id: 2212
Gene Symbol: FCGR2A
FCGR2A
0.010 GeneticVariation disease BEFREE A genetic single nucleotide polymorphism in the Fc gamma RIIa gene, resulting in arginine (R) or histidine (H) at position 131, affects the binding to the different IgG subclasses and may influence the clinical variations seen in onchocerciasis. 18165525 2007
Entrez Id: 2212
Gene Symbol: FCGR2A
FCGR2A
0.010 GeneticVariation disease LHGDN Fc gamma RIIa (CD32) polymorphism and onchocercal skin disease: implications for the development of severe reactive onchodermatitis (ROD). 18165525 2007
Entrez Id: 3596
Gene Symbol: IL13
IL13
0.010 GeneticVariation disease BEFREE Genotyping for the IL-13 variant Arg110Gln revealed a highly significant association of Arg110Gln with the sowda form (relative risk of 2.98, n = 19 patients), whereas the frequency of the variant was significantly lower in patients with generalized onchocerciasis (n = 92 individuals). 11825773 2002
Entrez Id: 3565
Gene Symbol: IL4
IL4
0.010 Biomarker disease BEFREE Here we show that in the chronic helminth infection onchocerciasis (river blindness), where patients have relatively little sign of dermatitis despite the presence of millions of small worms in the skin, T cells can be obtained which bear characteristics of Tr1 cells, producing no IL-2 or IL-4 but substantial amounts of IL-10, variable amounts of IL-5, and some IFN-gamma. 12443893 2002
Entrez Id: 3596
Gene Symbol: IL13
IL13
0.010 GeneticVariation disease LHGDN The variant Arg110Gln of human IL-13 is associated with an immunologically hyper-reactive form of onchocerciasis (sowda). 11825773 2002
Entrez Id: 3329
Gene Symbol: HSPD1
HSPD1
0.010 Biomarker disease BEFREE It is concluded that antibody responses to Ov-CPN60 are unlikely to contribute either to host protection or pathology in onchocerciasis. 10779593 2000
Entrez Id: 2938
Gene Symbol: GSTA1
GSTA1
0.010 AlteredExpression disease BEFREE Low but significant IgG levels were observed against OvSOD1 in patients with onchocerciasis; higher antibody levels were found against OvGST2 in patients and endemic normals. 9294549 1997